Purpose. To compare the through-focus visual performance in a clinical population of pseudophakic patients implanted with two new trifocal intraocular lenses (IOLs) and one extended depth of focus IOL. Methods. Prospective, nonrandomized, examiner-masked case series. Twenty-three patients received the FineVision? and seven patients received the PanOptix? trifocal IOLs. Fifteen patients received the Symfony extended depth of focus IOL. Mean age of patients was 63?±?8 years. Through-focus visual acuity was measured from –3.00 to
展开▼
